STOCK TITAN

RPRX: Entities report multi‑date sell notices including 136,980‑share trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Reporting persons filed Form 144 reporting proposed and completed sales of Common Stock of RPRX. The excerpt lists multiple transactions by related entities, including sales on 12/17/2025, 01/07/2026, and 03/18/2026, with individual trade sizes such as 79,346, 123,965, and 100,462 shares respectively. Examples shown include sales by GWL 2014 G LLC (79,346 shares on 12/17/2025) and George Lloyd IRA (136,980 shares on 03/04/2026). The filing records gross proceeds for each sale in U.S. dollars alongside the share counts.

Positive

  • None.

Negative

  • None.

Insights

Multiple related entities reported open-market sales of Common Stock with dated transactions and per-trade proceeds.

These Form 144 entries list discrete sale dates and per-trade gross proceeds, for example $3,060,280 for 79,346 shares on 12/17/2025 and $6,507,851.31 for 136,980 shares on 03/04/2026. The filings identify the selling parties by entity names such as GWL 2013 NG LLC and George Lloyd IRA.

Form 144 is a notice of proposed sale under the Securities Act; it does not itself complete trades. Confirmatory broker records or Form 4/5 entries may show whether all reported proposals were executed; subsequent public filings would provide that confirmation.

Reported transactions show large single-day blocks that could affect float if executed off-market.

The excerpt lists multiple sizable single-day sales: e.g., 123,965 shares with proceeds $5,093,114.42 on 01/07/2026, and 100,462 shares with proceeds $4,602,234.54 on 03/18/2026. These are per-trade figures reported alongside broker identification.

Execution method and timing are not described here; liquidity and price impact depend on whether sales were block trades, brokered transactions, or open-market dispositions. Subsequent transaction-level reports would clarify market impact.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for RPRX report?

The Form 144 reports proposed and recent sales of RPRX Common Stock by named entities. It lists sale dates and per-trade share counts such as 79,346 and 123,965, with corresponding gross proceeds in dollars.

Who are the selling parties named in the RPRX excerpt?

The excerpt names entities including GWL 2014 G LLC, GWL 2013 NG LLC, and George Lloyd IRA. Each entity is listed with specific sale dates and share counts tied to those transactions.

Do the Form 144 entries confirm trades were completed?

Form 144 entries are notices of proposed sales and list dates and amounts. They do not by themselves confirm settlement; execution confirmation would appear in broker records or subsequent Forms 4/5.

What sizes and proceeds are shown in the excerpt?

Individual sale sizes include examples such as 136,980 shares for $6,507,851.31 on 03/04/2026 and 100,462 shares for $4,602,234.54 on 03/18/2026, with per-trade gross proceeds reported.

Which broker-dealer is identified for these transactions?

The excerpt lists Goldman Sachs & Co. LLC at 200 West Street, New York, NY as the broker-dealer associated with the securities to be sold in the filing.
Royalty Pharma Plc

NASDAQ:RPRX

View RPRX Stock Overview

RPRX Rankings

RPRX Latest News

RPRX Latest SEC Filings

RPRX Stock Data

19.51B
396.11M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK